| Bioactivity | Doxorubicin-13C,d3 (TFA) is the deuterium and 13C labeled Doxorubicin. Doxorubicin (Hydroxydaunorubicin), a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin inhibits topoisomerase II with an IC50 of 2.67 μM, thus stoppin |
| Invitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Doxorubicin-13C,d3 (TFA) has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| Name | Doxorubicin-13C,d3 (TFA) |
| Formula | C2813CH27D3F3NO13 |
| Molar Mass | 661.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Doxorubicin-13C,d3 (TFA)
CAS: F: C2813CH27D3F3NO13 W: 661.55
Doxorubicin-13C,d3 (TFA) is the deuterium and 13C labeled Doxorubicin. Doxorubicin (Hydroxydaunorubicin), a cytotoxic an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.